Infection & Infectious Diseases - Fungal & Viral Infections - PDF
Document Details
![QuieterDiscernment9434](https://quizgecko.com/images/avatars/avatar-2.webp)
Uploaded by QuieterDiscernment9434
Samuel Merritt University
Tags
Related
Summary
These lecture notes from Samuel Merritt University discuss fungal and viral infections and are intended for students of pathopharmacology. Topics include the etiology of fungal and viral infections, as well as treatments using antifungal and antiviral agents. The document also covers HIV and AIDS, including treatment implications for those infections.
Full Transcript
multiple protectivelayers makes harder kill andmake need to penetrate it to fungi can also grow in convonment Unicellular multicellular white multi color microscopic visible cancer glucocortic...
multiple protectivelayers makes harder kill andmake need to penetrate it to fungi can also grow in convonment Unicellular multicellular white multi color microscopic visible cancer glucocorticoid organtransplant HIV AIDS agriculture systemic or topical longduration of use 6 12 months fungalinfection dit thick cell wall moretoxic than alex fungus cango systemic non communicable tinea versicolor usually locatedin rings valley fever dont need to know organism name nyastatin and amphotericin B manytypes w this ending don't need to know ONLYusedfor polyene systemicinfectie broad spectrum wallmore cell cause make permeable Leakage frontlents thattheyuse forfunction N F chilli HA rigor toxic kidney can'tretain kt WBC RBC platelet production relatedto cytokinerelease gavenormal same before infusion because dehydration can cause kidney to be more sensitive to medicine andcause movekidney toxicity toxin effect on kidney Slow IV 4 6hours need to know mechanism of action Slowprocess weeksto work G.I.SE putoinhibition hepatotoxicity hepatotoxic fungus have P45d enzymes fortheir metabolism and also affect human liver increase bloodlevel of other meds similar to polyere's azotes inhibitsynthesis of ergosterol in the cell war takes weeksto work instigation hepatoxicity r r Usually caused dermatophyte byyeast MTmembrane affected oral lavity infection does NOTspreadto skill to dithft not much 6 12 months Chulation leasteffective notas effective common in women less problematic no insurance coverage risk factor moisture MWM hwhnEff YtdmmMmnohh n common polyene Not systemic works locally less SE's does notabsorb in G I carrysgene not 60th aroundthe capsid stomachtw intracellular pathogen use cell to prodrition BEEEPladinitiet translation novaccine for HIV virus polio influenza COVID goal Herpes and varicella andvaricella HSV 1 oral HSV2genital shingles damage DNA of virus by blocking DNApolymerase acyclovir pretendsto be a thymine adds to acyclovir andgetsoheorporatedin Wal DNA blockpita cant replicate thymidine kinase generalfunction adds a phosphate group to thymidine building block of DNA butacyclovir does.no tx Family of ciclovir decreased WBCinblood bone marrow suppression absorbsthroughskin who recievesandnurses that administermeds communicable virus NOV March goesthrough airway notessomethrea commton cold butmove symptomatic cough rainy i hand hegume wear mash needsurgical mash POBID reducerish for 5 days induce S S pregnantwomen encymenoususeto release itself frominfected all afterthat unshasspread aroundbody not superffective airborne need 1095 different strains of mthenia everyyear Tamifle reduces viralload helpsuns stuckin infectedcells to this pregnant women are often immunocompromised medication helps decrease risk needle injury IV drugs transmission increases if patient not compliant w medication or unaware are infected they transmission chanceis reduced if patient compliant w HIV meds retyped.tn an RNAgetsinto whenuval iteration same CPU youngest convert viral orangecolor places where medscan receptyles intervene infightinginside assertion thticles DNAproduced can byvirus getin nuchal integrase of cell and enzymehelps ans getinto orange CDU DNA boxes are where places intervene Uwstakingover medscan ODY and some of making elements of vini Seroconversion Clinical CD4 200 latency vapidvirus production and or virus enters plasma and an opportunistic multiply inblood pathogens arise HIV become activega platave OCCUS 2 4 week after exposure CD4 countstill normal or slightly decreased high viral load non specific symptoms can last years CD4 count gradually decimes overtime 1 and 2 take several years stage to complete alt platane andstopactivity StephenEnough immunocompromised status causing manifestation of many infections fungus canspread upto smallintestine uncommon types of pneumonia not seen in general population no care but tx is very successful AIDS stage advanced HIV infection and manifestation of opportunistic injections whento use ART or HAART stage compliance underlying immone condition 2 3 anti viral viral load 3 anti viral meds more effective Usedfor degree of Uwslevel inblood willthe patient becompliant i Payphone'sde a KÑA DNA transcribe Emtriva MTDNA UNS components accidentlypicks Vivead up this block cause incomplete DNA strand liverdisease NIV D appetiteloss diarrhea common Block of the enzyme mostcommon don't need to med remembernames Efavirenzspecifically can'tuse on pregnant women 6 I.SE inhibit from assembling the virus first anti viral medication created common w the ored increased risk of metabolicsyndrome and diabetes end w navir newer gen of HIV med prevent DNA of nwsfrom entering CD4 cells Dolutegravir Tivicay inconclusive HIV fusion inhibitor bindto 68120 viral receptor which prevents nws from attaching to CDU injectible CCR 5 antagonist receptor on CD4 that yous bindsto CCRs receptor on the Astor cardiac toxicity fusion process one tablet increases patient compliance standard of care 2 NRTI's and I integrase inhibitors healthy person usually thousands in HIV infection below1000count betoknsidered AIDS highest rate of multiplying and undetectable within the first few weeks and highest rate of transmission after initial exposure non compliance or usingone med at once can increase risk of resistance most anti viral meds safe to take during pregnancy makes vows in active andtransmission ratereduces becomes undetectable zero chance I a prenatal transmission can happen if compliant w meds exposure in healthcare prophylaxis treatment what is chance of HIV transmission for patient who is NOT ontherapy 25 by any exposure aka like needle inory or sexual intercourse w treatment chance of transmission almost 0 no vaccines get mutations several host targets CDU main elements of immune system and difficult to target w o hurting the host ways of transmission med classes 5 MOC side effects G I common majority of HIV meds have diarrhea SE 2 NRTI and integrate classes are the standard of care rate of contamination is not high w one exposure